Structure-activity relationship of flavonoid bifunctional inhibitors against Zika virus infection

被引：40
|
作者：
Zou, Min [1 ]
Liu, Hongmiao [1 ]
Li, Jingyan [1 ]
Yao, Xingang [1 ]
Chen, Yi [1 ]
Ke, Changwen [2 ]
Liu, Shuwen [1 ]
机构：
[1] Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab New Drug Screening, Guangzhou Key Lab Drug Res Emerging Virus Prevent, 1838 Northern Guangzhou Rd, Guangzhou 510515, Peoples R China
[2] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China
来源：
BIOCHEMICAL PHARMACOLOGY | 2020年 / 177卷
关键词：
Zika virus; Flavonoids; Antiviral; Entry inhibitors; Protease; NS2B-NS3; PROTEASE; FLAVIVIRUS; COMPOUND; SURAMIN; CELLS; ENTRY; REPLICATION; EGCG;
D O I：
10.1016/j.bcp.2020.113962
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Zika virus (ZIKV) infection is a global public health problem due to its rapid spread and the possibility of causing microcephaly. Currently, no specific antivirals against ZIKV are available for treatment. In the present study, several flavonoids (galangin, kaempferide, quercetin, myricetin and EGCG) were found to reduce ZIKV induced plaques and viral RNA copies with negligible cytotoxic effects on host cells. In addition, inhibition of ZIKV propagation by flavonoids showed structure-activity relationship. Our results demonstrate flavonoids as inhibitors of ZIKV entry and NS2B-NS3 protease. Hence, these flavonoids could be used as potential bifunctional drugs for treating ZIKV infections.
引用
收藏
页数：9
相关论文
共 50 条
  • [41] Structure-Activity Relationship Studies with Tetrahydroquinoline Analogs as EPAC Inhibitors
    Sonawane, Yogesh A.
    Zhu, Yingmin
    Garrison, Jered C.
    Ezell, Edward L.
    Zahid, Muhammad
    Cheng, Xiaodong
    Natarajan, Amarnath
    ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (11): : 1183 - 1187
  • [42] Synthesis and structure-activity relationship studies of novel PSMA inhibitors
    Wang, Haofan
    Byun, Youngjoo
    Pullambhatla, Mrudula
    Bhang, Hyo-eun C.
    Fox, James
    Mease, Ronnie C.
    Pomper, Martin G.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [43] Synthesis and structure-activity relationship of inhibitors of protein kinase D
    Rosenker, Kara M. George
    Bravo-Altamirano, Karla
    Frantz, Marie-Celine
    LaValle, Courtney R.
    Tandon, Manuj
    Wang, Q. Jane
    Wipf, Peter
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [44] A structure-activity relationship study of ABCC2 inhibitors
    Wissel, Gloria
    Deng, Feng
    Kudryavtsev, Pavel
    Ghemtio, Leo
    Wipf, Peter
    Xhaard, Henri
    Kidron, Heidi
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 103 : 60 - 69
  • [45] The synthesis and structure-activity relationship of pyridazinones as glucan synthase inhibitors
    Ting, Pauline C.
    Kuang, Rongze
    Wu, Heping
    Aslanian, Robert G.
    Cao, Jianhua
    Kim, David W.
    Lee, Joe F.
    Schwerdt, John
    Zhou, Gang
    Wainhaus, Samuel
    Black, Todd A.
    Cacciapuoti, Anthony
    McNicholas, Paul M.
    Xu, Yiming
    Walker, Scott S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (06) : 1819 - 1822
  • [46] Dihydroorotate Dehydrogenase Inhibitors: Quantitative Structure-activity Relationship Analysis
    Shijun Ren
    Sharon K. Wu
    Eric J. Lien
    Pharmaceutical Research, 1998, 15 : 286 - 295
  • [47] Synthesis and structure-activity relationship studies of cruzain and rhodesain inhibitors
    Rocha, Debora A.
    Silva, Elany B.
    Fortes, Isadora S.
    Lopes, Marcela S.
    Ferreira, Rafaela S.
    Andrade, Saulo F.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 157 : 1426 - 1459
  • [48] Structure-Activity Relationship for Thiirane-Based Gelatinase Inhibitors
    Lee, Mijoon
    Ikejiri, Masahiro
    Klimpel, Dennis
    Toth, Marta
    Espahbodi, Mana
    Hesek, Dusan
    Forbes, Christopher
    Kumarasiri, Malika
    Noll, Bruce C.
    Chang, Mayland
    Mobashery, Shahriar
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (06): : 490 - 495
  • [49] Dihydroorotate dehydrogenase inhibitors: Quantitative structure-activity relationship analysis
    Ren, SJ
    Wu, SK
    Lien, EJ
    PHARMACEUTICAL RESEARCH, 1998, 15 (02) : 286 - 295
  • [50] Classification Structure-Activity Relationship Study of Reverse Transcriptase Inhibitors
    Seyagh, Maria
    Mazouz, E. L. Mostapha
    Schmitzer, Andreea
    Villemin, Didier
    Jarid, Abdellah
    Cherqaoui, Driss
    LETTERS IN DRUG DESIGN & DISCOVERY, 2011, 8 (07) : 585 - 595
12345